| General Information of DME (ID: DME1754) |
| DME Name |
Unclear metabolic mechanism (DME-unclear), Enterococcus gilvus
|
| Gene Name |
DME-unclear
|
| Lineage |
Species: Enterococcus gilvus (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilli
Order: Lactobacillales
Family: Enterococcaceae
Genus: Enterococcus
Species: Enterococcus gilvus
|
|
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME
|
| Tissue Distribution |
Primarily distributed in human gut.
|
|
|
|
|
|
|
| Full List of Drug(s) Metabolized by This DME |
|
Drugs in Phase 4 Clinical Trial
|
Click to Show/Hide the Full List of Drugs: 1 Drugs
|
Quercetin |
Drug Info
|
Phase 4 |
Hypertriglyceridaemia
|
ICD11: 5C80
|
[1] |
|
|
|
|
|
|
| References |
| 1 |
Isolation and identification of quercetin degrading bacteria from human fecal microbes. PLoS One. 2014 Mar 4;9(3):e90531.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
